Pyrazinecarboxamide
Pyrazinecarboxamide Brand names, Pyrazinecarboxamide Analogs
- Aldinamid
- Aldinamide
- Braccopiral
- Corsazinmid
- Dipimide
- Eprazin
- Farmizina
- Isopas
- Lynamide
- Novamid
- Pyrazinamdie
- PZA
- Pezetamid
- Piraldina
- Pirazimida
- Pirazinamid
- Pirilene
- Prazina
- Pyrafat
- Pyramide
- Pyrazide
- Pyrazinamide BP 2000
- Pyrazine carboxylamide
- Pyrazineamide
- Pyrazinecarboxamide
- Pyrazinecarboxylic acid amide
- Pyrazinoic acid amide
- Rifater
- Rozide
- Tebrazid
- Tebrazio
- Unipyranamide
- Zinamide
- Zinastat
- pms-Pyrazinamide
Pyrazinecarboxamide Brand Names Mixture
- No information avaliable
Pyrazinecarboxamide Chemical_Formula
C43H51N3O11
Pyrazinecarboxamide RX_link
http://www.rxlist.com/cgi/generic/xifaxan.htm
Pyrazinecarboxamide fda sheet
Pyrazinecarboxamide msds (material safety sheet)
Pyrazinecarboxamide Synthesis Reference
No information avaliable
Pyrazinecarboxamide Molecular Weight
785.879 g/mol
Pyrazinecarboxamide Melting Point
No information avaliable
Pyrazinecarboxamide H2O Solubility
No information avaliable
Pyrazinecarboxamide State
No information avaliable
Pyrazinecarboxamide LogP
4.161
Pyrazinecarboxamide Dosage Forms
No information avaliable
Pyrazinecarboxamide Indication
For the treatment of patients (>=12 years of age) with travelers' diarrhea caused by noninvasive strains of Escherichia coli.
Pyrazinecarboxamide Pharmacology
Rifaximin is a structural analog of rifampin and non-systemic, gastrointestinal site-specific antibiotic. Rifaximin acts by inhibiting bacterial ribonucleic acid (RNA) synthesis. While an increase in pulmonary hydrogen excretion is evident in diverticular disease, the therapeutic effect of rifaximin does not appear to be due to a persistent correction of this alteration and the drug appears to cause no significant imbalance in the intestinal ecosystem.
Pyrazinecarboxamide Absorption
Low absorption in both the fasting state and when administered within 30 minutes of a high-fat breakfast.
Pyrazinecarboxamide side effects and Toxicity
LD50 > 2 g/kg (orally, in rats)
Pyrazinecarboxamide Patient Information
No information avaliable
Pyrazinecarboxamide Organisms Affected
Enteric bacteria and eubacteria
